CASTRATION RESISTANT PROSTATIC CANCER
Clinical trials for CASTRATION RESISTANT PROSTATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATION RESISTANT PROSTATIC CANCER trials appear
Sign up with your email to follow new studies for CASTRATION RESISTANT PROSTATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested to stall advanced prostate cancer
Disease control OngoingThis study is testing whether adding a drug called niraparib to a standard treatment (abiraterone acetate plus prednisone) works better than the standard treatment alone for men with advanced prostate cancer that has spread. It aims to see if the combination can delay the cancer …
Matched conditions: CASTRATION RESISTANT PROSTATIC CANCER
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Scientists scan brains to see if cancer drugs cause 'Chemo Brain'
Knowledge-focused OngoingThis study aims to understand if two common prostate cancer drugs, abiraterone and enzalutamide, affect memory, concentration, and other thinking skills. Researchers will use brain scans and cognitive tests to compare 100 men with advanced prostate cancer who are taking these dru…
Matched conditions: CASTRATION RESISTANT PROSTATIC CANCER
Phase: PHASE4 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC